Dexcom, Inc. · NASDAQ:DXCM

Dexcom — Q3 2023 Earnings Presentation

11 slides from Dexcom's earnings presentation, Oct 26, 2023

  1. Slide 1: Dexcom earnings Q3 2023

    bpexcom Dexcom earnings Q3 2023

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement pexcom This presentation contains "forward" looking statements that are based on our management's beliefs and assumptions and on information currently available to management. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-

  3. Slide 3: Third quarter 2023 key financial and strategic highlights

    Third quarter 2023 iil Strong growth with $975 million in revenue 26% organic revenue growth! (24% US; 30% OUS?) 1 2. pexcom Key Financial Highlights Generated over 300 basis points of operating expense leverage compared to Q3'22 Delivered ~50% growth in non-GAAP operating income compared to Q3'22 O

  4. Slide 4: Third quarter performance

    Third quarter performance Total Revenue & Organic Growth Rate! Non-GAAP Gross Profit and % Margin* ($m™) ($MM) $975 $1,000 $815 $871 $750 630 gs00 | 28770 $741 $600 $494 $544 $270 $553 $ $600 $450 $400 $300 $200 | Flees +20% +19% +26% +26% BOM 64.2% 66.7% 63.4% 63.5% 64.7% $0 $0 Q3'22 Q4'22 Q123 Q2'

  5. Slide 5: 2023 Guidance as of October 26, 2023

    2023 Guidance as of October 26, 2023 2023 Annual Revenue and Profitability Guidance Non-GAAP Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin* . USD Previous 3.500-3.550 ~63% ~17% ~26.5% billion USD Updated 3.575-3.600 ~64% ~19% ~28% billion “Adjusted EBITDA defined as

  6. Slide 6: Appendix: Revenue Data and GAAP Reconciliations

    bexcom Appendix Revenue Data and GAAP Reconciliations

  7. Slide 7: GAAP to non-GAAP reconciliations

    Three Months Ended September 30, Three Months Ended September 30, (In millions) 2023 2022 (In millions, except per share data) 2023 2022 GAAP gross profit $ 623.3 $ 494.2 GAAP net income $ 120.7 $ 101.2 Amortization of intangible assets (1) 7.1 — Amortization of intangible assets (1) 8.8 1.8 Non-GAA

  8. Slide 8: Revenue Metrics By Component

    Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 YTD' 21 YTD' 22 YTD' 23 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 424.3 $ 494.5 $ 547.9 $ 598.6 $ 543.2 $ 597.7 $ 666.6 $ 714.8 $ 651.9 $ 778.0 $ 873.8 $ 1,466.7 $ 1,807.5 $ 2,303.7 Year over year growth

  9. Slide 9: Revenue Metrics By Geography

    Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 YTD' 21 YTD' 22 YTD' 23 Revenue Metrics By Geography US Revenue (millions) $ 381.2 $ 461.5 $ 489.6 $ 517.1 $ 451.2 $ 511.0 $ 573.4 $ 606.4 $ 526.0 $ 616.6 $ 713.6 $ 1,332.3 $ 1,535.6 $ 1,856.2 Year over year growth 30% 26% 23% 15% 18%

  10. Slide 10: Organic Revenue

    Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 YTD' 21 YTD' 22 YTD' 23 1 Organic Revenue INT'L Revenue - Reported $ 123.8 $ 133.6 $ 160.6 $ 181.1 $ 177.6 $ 185.2 $ 196.2 $ 208.8 $ 215.5 $ 254.7 $ 261.4 $ 418.0 $ 559.0 $ 731.6 Impact of Acquired Revenue and Foreign Exchange (5.4) (

  11. Slide 11: Definitions

    DexCom, Inc. Definitions: Amortization of intangible assets — We are required by GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful ives. We exclude these non-cash amortization charges related to acquired intangible assets f

DexCom — Q3 2023 Earnings Presentation on 6ix